| Announce Date | 10/15/2025 |
| EPS Normalized Actual | $4.05 (Miss by $-0.94) |
| EPS GAAP Actual | $4.05 (Miss by $-0.94) |
| Revenue Actual | $22.502B |
| Revenue Surprise | Beat by $22502M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $2.64251 |
| EPS GAAP Estimate | $2.64251 |
| Revenue Estimate | $20.763991829B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 15.99813 | 13.4 | 15.29675 | 16.6093 | 4 |
| Dec 2025 | 9.59 | 22.36 | 8.3 | 10.9 | 8 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 4.45 | 1.80385 | 22.502B | 12.4% | 2654.26M |
| FQ2 2025 (Jun 2025) | 5.42 | 5.42 | 21.995B | 19.25% | 21995M |
| FQ1 2025 (Mar 2025) | 4.38 | 4.38 | 0B | -INF% | 0M |
| FQ4 2024 (Dec 2024) | 4.02 | 4.02 | 20.2672B | 20.68% | 20267.2M |
| FQ3 2024 (Sep 2024) | 3.98 | 3.98 | 19.7118B | 21.1% | 19711.8M |
| FQ2 2024 (Jun 2024) | 2.49 | 2.49 | 17.7609B | 13.59% | 17760.9M |
| FQ1 2024 (Mar 2024) | 3.94 | 3.94 | 17.2368B | 17.05% | 17236.8M |
| FQ4 2023 (Dec 2023) | 3.38 | 3.38 | 16.076B | 16.25% | 16076M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
2.64251
Consensus Revenue Estimates
20.763991829B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.3978 | -- | 4.07589 | 4.73475 | 5 |
| FQ3 2027 (Sep 2027) | 3.72768 | -- | 3.45482 | 4.01329 | 5 |
| FQ2 2027 (Jun 2027) | 3.64031 | -- | 3.37385 | 3.91922 | 5 |
| FQ1 2027 (Mar 2027) | 4.23234 | -- | 3.92254 | 4.55661 | 5 |
| FQ4 2026 (Oct 2026) | 2.71775 | -- | 2.55198 | 2.88286 | 9 |
| FQ3 2026 (Jul 2026) | 2.752 | -61.7 | 2.58414 | 2.91919 | 9 |
| FQ2 2026 (Jun 2026) | 2.69145 | -101.38 | 2.53633 | 2.83161 | 9 |
| FQ1 2026 (Mar 2026) | 3.4718 | -26.16 | 3.2717 | 3.6526 | 9 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 23.53B | -- | 22.21B | 24.92B | 3 |
| FQ3 2027 (Sep 2027) | 26.28B | -- | 24.8B | 27.83B | 3 |
| FQ2 2027 (Jun 2027) | 24.84B | -- | 23.44B | 26.31B | 3 |
| FQ1 2027 (Mar 2027) | 26.92B | -- | 25.4B | 28.51B | 3 |
| FQ4 2026 (Oct 2026) | 22.43B | -- | 21.37B | 23.47B | 4 |
| FQ3 2026 (Jul 2026) | 21.23B | -5.98 | 20.24B | 22.22B | 4 |
| FQ2 2026 (Jun 2026) | 20.79B | -5.79 | 19.87B | 21.62B | 4 |
| FQ1 2026 (Mar 2026) | 22.38B | -- | 21.39B | 23.28B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.64615 | 4.45 | 1.80385 | 40.54% |
| FQ2 2025 (Jun 2025) | 5.42 | 5.42 | 100% | |
| FQ1 2025 (Mar 2025) | 4.38 | 4.38 | 100% | |
| FQ4 2024 (Dec 2024) | 4.02 | 4.02 | 100% | |
| FQ3 2024 (Sep 2024) | 3.98 | 3.98 | 100% | |
| FQ2 2024 (Jun 2024) | 2.49 | 2.49 | 100% | |
| FQ1 2024 (Mar 2024) | 3.94 | 3.94 | 100% | |
| FQ4 2023 (Dec 2023) | 3.38 | 3.38 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $19.85B | $22.5B | $2654.26M | 11.8% |
| FQ2 2025 (Jun 2025) | $0B | $22B | $21995M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
| FQ4 2024 (Dec 2024) | $0B | $20.27B | $20267.2M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $19.71B | $19711.8M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $17.76B | $17760.9M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $17.24B | $17236.8M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $16.08B | $16076M | 100% |